Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 2

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 2
---
 other hand, you should rely
on the information in this prospectus supplement. However, if any statement in one of these documents is inconsistent with a statement
in another document having a later date - for example, a document incorporated by reference in this prospectus supplement - the statement
in the document having the later date modifies or supersedes the earlier statement as our business, financial condition, results of operations
and prospects may have changed since the earlier date.

We further note that the representations,
warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference into
this prospectus supplement or the accompanying prospectus were made solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties to such agreement, and should not be deemed to be a representation,
warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly,
such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.

You should rely only on this
prospectus supplement, the accompanying prospectus and the information incorporated or deemed to be incorporated by reference in this
prospectus supplement and the accompanying prospectus. We have not authorized anyone to provide you with information that is in addition
to or different from that contained or incorporated by reference in this prospectus supplement and the accompanying prospectus. We take
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are not,
and the Placement Agent is not, offering to sell these securities in any jurisdiction where the offer or sale is not permitted. You should
not assume that the information contained or incorporated by reference in this prospectus supplement is accurate as of any date other
than as of the date of this prospectus supplement or in the case of the documents incorporated by reference, the date of such documents
regardless of the time of delivery of this prospectus supplement or any sale of our common stock. Our business, financial condition, liquidity,
results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the accompanying prospectus,
the documents incorporated by reference, and any free writing prospectus that we may authorize for use in connection with this offering,
in their entirety before making an investment decision. You should also read and consider the information in the